Good piece on why M&A might be ready to pick up in biotech, who the major acquirers are likely to…

Good piece on the top ten late stage potential blockbusters in the biotech sector right now.
…

Interesting development if you own SCYNEXIS…

Good piece on why Global Blood Therapeutics might be down today despite solid results on primary…

Good piece on the ridiculous hard economics of the antibiotic space even with newly approved drugs…

Good piece on the current regulatory delays and possible impacts around Spark Therapeutics…

Good piece on the progress Blueprint Medicine is making on a variety of oncology fronts. …

Good piece on Nektar and the presentations they are making at the big ASCO event this week. …

Iovance to be the pre-ASCO winner as far as getting positive press before…

Very good and extensive piece on five things investors should forward to at the big ASCO event that…